Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Price Performance NASDAQ:BPTH opened at $1.42 […]
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Down 2.8 % Shares of BPTH opened at […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 83,600 shares, a growth of 10.0% from the March 31st total of 76,000 shares. Based on an average daily volume of 35,400 shares, the days-to-cover ratio is […]
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened at […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report released on Saturday. The firm issued a sell rating on the stock. Separately, Roth Capital reissued a buy rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened at $1.38 on Friday. […]